Cargando…
Opportunities to improve immune-based prevention of HPV-associated cancers
Immunization of adolescent girls with VLP vaccines, made of L1 proteins from the most medically significant high risk HPV types, is a major strategy for prevention of cervical cancer plus other HPV-associated cancers. Maximal population impact, including through herd immunity, requires high vaccinat...
Autores principales: | Stern, Peter L., Roden, Richard BS. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468155/ https://www.ncbi.nlm.nih.gov/pubmed/30980968 http://dx.doi.org/10.1016/j.pvr.2019.04.010 |
Ejemplares similares
-
Immunizing against Anogenital Cancer: HPV Vaccines
por: Pogoda, Cloe S., et al.
Publicado: (2016) -
Cervarix(™): a vaccine for the prevention of HPV 16, 18-associated cervical cancer
por: Monie, Archana, et al.
Publicado: (2008) -
Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells
por: Peng, Shiwen, et al.
Publicado: (2014) -
K.03 HPV vaccines: New opportunities for global cervical cancer prevention
por: Bosch, F.X.
Publicado: (2009) -
Progress in eliminating HPV-associated disease
por: Stern, Peter L., et al.
Publicado: (2019)